mRNA expression of growth factors in glomeruli from diabetic rats - PubMed (original) (raw)
mRNA expression of growth factors in glomeruli from diabetic rats
T Nakamura et al. Diabetes. 1993 Mar.
Abstract
Evaluations of glomerular mRNA levels encoding for PCNA, TNF-alpha, PDGF-A and -B chains, TGF-beta, IGF-I, bFGF, and EGF were made at 4, 12, and 24 wk after injection of STZ in Sprague-Dawley rats. The mRNA levels for PCNA, TNF-alpha, PDGF-B chain, TGF-beta, and bFGF increased with age in STZ-induced diabetic rats. At 24 wk after STZ injection, mRNA levels for PCNA, TNF-alpha, PDGF-B chain, TGF-beta, and bFGF were increased 3.8-fold, (P < 0.01), 4.2-fold (P < 0.01), 4.0-fold (P < 0.01), 5.2-fold (P < 0.001), and 3.6-fold (P < 0.01), respectively, in the glomeruli of diabetic rats when compared with control rats. In contrast, mRNA levels for IGF-I, PDGF-A chain, and EGF were not altered in glomeruli from diabetic and control rats throughout the experimental period. Insulin treatment partially ameliorated the increase in mRNA levels for PCNA, TNF-alpha, PDGF-B chain, TGF-beta, and bFGF in the glomeruli of diabetic rats. These data indicate that alterations in growth factor mRNA levels in glomeruli may be a manifestation of diabetic nephropathy, and that hyperglycemia or insulin deficiency may play a role in abnormal growth factor gene regulation.
Similar articles
- Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis.
Nakamura T, Ebihara I, Fukui M, Osada S, Nagaoka I, Horikoshi S, Tomino Y, Koide H. Nakamura T, et al. Clin Immunol Immunopathol. 1993 Jan;66(1):33-42. doi: 10.1006/clin.1993.1005. Clin Immunol Immunopathol. 1993. PMID: 8095004 - Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats.
Nakamura T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H. Nakamura T, et al. Ren Physiol Biochem. 1994 Nov-Dec;17(6):316-25. doi: 10.1159/000173864. Ren Physiol Biochem. 1994. PMID: 7533311 - Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli.
Fukui M, Nakamura T, Ebihara I, Makita Y, Osada S, Tomino Y, Koide H. Fukui M, et al. J Lab Clin Med. 1994 May;123(5):763-8. J Lab Clin Med. 1994. PMID: 8195682 - Alteration of growth-related proto-oncogene expression in diabetic glomeruli by a specific endothelin receptor A antagonist.
Nakamura T, Ebihara I, Tomino Y, Koide H. Nakamura T, et al. Nephrol Dial Transplant. 1996 Aug;11(8):1528-31. Nephrol Dial Transplant. 1996. PMID: 8856205 - Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli.
Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H. Nakamura T, et al. Diabetes. 1995 Aug;44(8):895-9. doi: 10.2337/diab.44.8.895. Diabetes. 1995. PMID: 7621993
Cited by
- Identification and validation of key extracellular proteins as the potential biomarkers in diabetic nephropathy.
Pan W, Zhang Q, Gong X, Wu W, Zhou Q. Pan W, et al. Eur J Med Res. 2024 Oct 26;29(1):517. doi: 10.1186/s40001-024-02120-y. Eur J Med Res. 2024. PMID: 39456069 Free PMC article. - Improvement effects of transplanting pancreatic islet that previously incubated with biomaterials on the diabetic nephropathy in STZ- diabetic rats.
Nemati M, Hosseinzadeh Z, Nemati F, Koohpeyma F. Nemati M, et al. BMC Nephrol. 2024 May 9;25(1):156. doi: 10.1186/s12882-024-03572-4. BMC Nephrol. 2024. PMID: 38724923 Free PMC article. - Non-reducing End of Heparin Tri-saccharide is a Scavenger Tool to Detoxify the Glucose Toxicity in Diabetes.
Wang AJ, Wang A, Hascall VC. Wang AJ, et al. J Cell Immunol. 2023;5(3):82-86. doi: 10.33696/immunology.5.171. J Cell Immunol. 2023. PMID: 37885773 Free PMC article. - SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation.
Klen J, Dolžan V. Klen J, et al. Pharmaceutics. 2023 Jul 20;15(7):1995. doi: 10.3390/pharmaceutics15071995. Pharmaceutics. 2023. PMID: 37514181 Free PMC article. Review. - Glucosamine inhibits extracellular matrix accumulation in experimental diabetic nephropathy.
Teuma L, Eshwaran R, Tawokam Fongang U, Wieland J, Shao F, Lagana ML, Wang Y, Agaci A, Hammes HP, Feng Y. Teuma L, et al. Front Nutr. 2022 Dec 1;9:1048305. doi: 10.3389/fnut.2022.1048305. eCollection 2022. Front Nutr. 2022. PMID: 36532524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous